The Future of Medication Abortion: Regulation and Ongoing Ligation

Description

Lunch will be provided.

Please join the Solomon Center for Health Law and Policy at Yale Law School for a discussion of issues related to medication abortion access in the wake of Dobbs v. Jackson Women’s Health Organization. This panel of FDA law experts will address a recent challenge to the FDA’s approval of mifepristone—one of two prescription drugs used for inducing medication abortions—and state-level restrictions on the drug that surpass those imposed by the federal agency. Panelists will also explore paths forward for preserving access to medication abortion, including preemption challenges based on the FDA’s regulatory authority.

Speakers include: 

• Lewis Grossman – Professor of Law; Affiliate Professor of History, American University Washington College of Law

• Katherine Kraschel – Clinical Lecturer in Law, Research Scholar in Law, and Senior Advisor of the Solomon Center for Health Law and Policy, Yale Law School.

• Ameet Sarpatwari – Assistant Professor of Medicine, Harvard Medical School; Assistant Director of the Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital

• Patricia Zettler – Associate Professor, Moritz College of Law

 

Sponsoring Organization(s)

The Solomon Center for Health Law and Policy, Yale Health Law and Policy Society (YHeLPS), Journal on Regulation (JReg), Project on Reproductive Justice at Information Policy Society (PSRJ at ISP). 

Contact Information

Laurel Lyngklip

laurel.lyngklip@yale.edu